GLW
56
-5
EXPE
64
-5
CFG
42
-4
CSX
48
4
TRV
40
-2
EBAY
45
-2
TSCO
53
2
SRCL
55
-2
HPE
55
-2
GILD
42
-5
AMP
70
-3
HOG
33
3
CAG
36
-4
MCK
71
-3
CTAS
61
-3
USB
40
-2
RRC
45
-4
CSCO
51
-2
TDC
65
-2
TEL
72
-2
GLW
56
-5
EXPE
64
-5
CFG
42
-4
CSX
48
4
TRV
40
-2
EBAY
45
-2
TSCO
53
2
SRCL
55
-2
HPE
55
-2
GILD
42
-5
AMP
70
-3
HOG
33
3
CAG
36
-4
MCK
71
-3
CTAS
61
-3
USB
40
-2
RRC
45
-4
CSCO
51
-2
TDC
65
-2
TEL
72
-2
Financhill
Back

Principal Financial Group Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
46

PFG
Principal Financial Group

Last Price:
79.40
Seasonality Move:
3.54%
Buy
53

SRPT
Sarepta Therapeutics

Last Price:
158.06
Seasonality Move:
18.65%
Sell
46
Principal Financial Group (PFG) is a Sell

Is Principal Financial Group a Buy, Sell or Hold?

  • The current Principal Financial Group [PFG] share price is $79.65. The Score for PFG is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • PFG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $156.91. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PFG Stock Price Chart

What is Principal Financial Group's stock price today?

  • The Principal Financial Group share price today is $79.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PFG is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $156.91
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

PFG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 47.9 Sell
Chaikin Money Flow: 514495 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (78.3 - 81.74) Sell
Bollinger Bands (100): (78.83 - 83.41) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.17 Buy
Relative Strength Index (14 RSI): 68.43 Buy
Chaikin Money Flow: 1613298 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (113.82 - 142.64) Buy
Bollinger Bands (100): (118.8 - 136.1) Buy

PFG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.22 Buy
20-day SMA: 79.44 Buy
50-day SMA: 80.88 Sell
200-day SMA: 77.71 Buy
8-day EMA: 79.58 Buy
20-day EMA: 79.79 Sell
50-day EMA: 80.57 Sell
200-day EMA: 79.19 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 140.03 Buy
20-day SMA: 129.22 Buy
50-day SMA: 127.95 Buy
200-day SMA: 115.45 Buy
8-day EMA: 145.32 Buy
20-day EMA: 134.79 Buy
50-day EMA: 129.39 Buy
200-day EMA: 120.67 Buy

Principal Financial Group Earnings Growth & PFG Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.11 per share, an increase this year of $1.08 per share, and an increase next year of $0.96 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.

Principal Financial Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):